Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 195,555 | 168,979 | 32,570 | 40,037 | 33,420 |
| Cost of Goods | 33,512 | 29,546 | 590 | 1,167 | 910 |
| Gross Profit | 162,043 | 139,433 | 31,970 | 38,870 | 32,510 |
| Operating Expenses | 214,873 | 210,838 | 106,880 | 84,801 | 69,483 |
| Operating Income | -52,318 | -70,859 | -74,310 | -45,764 | -36,063 |
| Interest Expense | 4,365 | 6,518 | 190 | 489 | 711 |
| Other Income | 14,776 | 11,779 | 18,430 | 18,260 | 15,042 |
| Pre-tax Income | -41,907 | -65,598 | -56,070 | -27,993 | -21,732 |
| Income Tax | 1,199 | 888 | 0 | 0 | 0 |
| Net Income Continuous | -43,106 | -66,486 | -56,075 | -27,993 | -21,732 |
| Net Income | $-56,776 | $-66,486 | $-56,070 | $-27,993 | $-21,732 |
| EPS Basic Total Ops | -0.04 | -0.05 | -0.46 | -0.03 | -0.02 |
| EPS Basic Continuous Ops | -0.03 | -0.05 | -0.46 | -0.03 | -0.02 |
| EPS Diluted Total Ops | -0.04 | -0.05 | -0.46 | -0.03 | -0.02 |
| EPS Diluted Continuous Ops | -0.03 | -0.05 | -0.46 | -0.03 | -0.02 |
| EBITDA(a) | $-40,310 | $-58,236 | $-71,560 | $-42,781 | $-31,584 |